These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 1769467)

  • 1. [Contribution of 131I MIBG scintigraphy in the diagnosis of carcinoid tumors of the digestive tract. Experience of 14 cases].
    Siproudhis L; Lescouarc'h J; Bretagne JF; Bourguet P; Raoul JL; Etienne PL; Herry JY; Gosselin M
    Gastroenterol Clin Biol; 1991; 15(11):789-93. PubMed ID: 1769467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carcinoid tumors: iodine-131 MIBG scintigraphy.
    Hanson MW; Feldman JM; Blinder RA; Moore JO; Coleman RE
    Radiology; 1989 Sep; 172(3):699-703. PubMed ID: 2772175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of 131I-metaiodobenzylguanidine scintigraphy in the diagnosis of intestinal carcinoids].
    Bihl H; Sautter-Bihl ML; Wilhelm KR; Kimmig B
    Nuklearmedizin; 1987 Dec; 26(6):263-7. PubMed ID: 3438170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. I-123 MIBG imaging of metastatic carcinoid tumor from the rectum.
    Watanabe N; Seto H; Ishiki M; Shimizu M; Kageyama M; Wu YW; Nagayoshi T; Kamisaki Y; Kakishita M
    Clin Nucl Med; 1995 Apr; 20(4):357-60. PubMed ID: 7788995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and treatment of a carcinoid tumor using iodine-131 meta-iodobenzylguanidine.
    Hoefnagel CA; Den Hartog Jager FC; Van Gennip AH; Marcuse HR; Taal BG
    Clin Nucl Med; 1986 Mar; 11(3):150-2. PubMed ID: 3956021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 131I-meta-iodobenzylguanidine in the management of metastatic midgut carcinoid tumors.
    Sywak MS; Pasieka JL; McEwan A; Kline G; Rorstad O
    World J Surg; 2004 Nov; 28(11):1157-62. PubMed ID: 15490060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iodine-131 metaiodobenzylguanidine scintigraphy of carcinoid tumors.
    Feldman JM; Blinder RA; Lucas KJ; Coleman RE
    J Nucl Med; 1986 Nov; 27(11):1691-6. PubMed ID: 3772504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute liver necrosis induced by iodine-131-MIBG in the treatment of metastatic carcinoid tumors.
    Bongers V; de Klerk JM; Zonnenberg BA; de Kort G; Lips CJ; van Rijk PP
    J Nucl Med; 1997 Jul; 38(7):1024-6. PubMed ID: 9225784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical relevance of I-123/I-131-MIBG scintigraphy in intestinal carcinoid tumors].
    van de Flierdt E; Frank T; Laubenbacher C; Fink U; Bauer R; Langhammer HR; Pabst HW
    Nuklearmedizin; 1998 Jun; 37(4):129-33. PubMed ID: 9650212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [111IN-octreotide and 123I-MIBG scintigraphy in the diagnosis of small intestinal carcinoid tumors--results of a comparative investigation].
    Dresel S; Tatsch K; Zachoval R; Hahn K
    Nuklearmedizin; 1996 Apr; 35(2):53-8. PubMed ID: 8721576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful and unsuccessful approaches to imaging carcinoids: comparison of a radiolabelled tryptophan hydroxylase inhibitor with a tracer of biogenic amine uptake and storage, and a somatostatin analogue.
    Macfarlane D; Gonin J; Wieland D; Mangner T; Froelich J; Beierwaltes W; Shapiro B
    Eur J Nucl Med; 1996 Feb; 23(2):131-40. PubMed ID: 8925846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carcinoid tumors: CT and I-131 meta-iodo-benzylguanidine scintigraphy.
    Adolph JM; Kimmig BN; Georgi P; zum Winkel K
    Radiology; 1987 Jul; 164(1):199-203. PubMed ID: 3588904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined diagnostic imaging with 131I-metaiodobenzylguanidine and 111In-pentetreotide in carcinoid tumours.
    Taal BG; Hoefnagel CA; Valdés Olmos RA; Boot H
    Eur J Cancer; 1996 Oct; 32A(11):1924-32. PubMed ID: 8943676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-[131I]iodobenzylguanidine in the scintigraphic evaluation of neural crest tumors.
    Zagar I; Han R; Mitrovic S
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):13-6. PubMed ID: 9002742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of somatostatin analogue and metaiodobenzylguanidine scintigraphy for the detection of carcinoid tumours.
    Nocaudie-Calzada M; Huglo D; Carnaille B; Proye C; Marchandise X
    Eur J Nucl Med; 1996 Nov; 23(11):1448-54. PubMed ID: 8854840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Scintigraphy using I 131 iodobenzylguanidine and malignant melanomas].
    de Both PS; De Groot GH; Hoefnagel CA
    Ned Tijdschr Geneeskd; 1990 Oct; 134(42):2054-7. PubMed ID: 2234180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of I-131-MIBG in the diagnosis and therapy of carcinoids.
    Hoefnagel CA; den Hartog Jager FC; Taal BG; Abeling NG; Engelsman EE
    Eur J Nucl Med; 1987; 13(4):187-91. PubMed ID: 2441993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iodine-131 MIBG scintigraphy of neuroendocrine tumors other than pheochromocytoma and neuroblastoma.
    Von Moll L; McEwan AJ; Shapiro B; Sisson JC; Gross MD; Lloyd R; Beals E; Beierwaltes WH; Thompson NW
    J Nucl Med; 1987 Jun; 28(6):979-88. PubMed ID: 3035114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of [131I]metaiodobenzylguanidine therapy in carcinoids.
    Hoefnagel CA; Taal BG; Valdés Olmos RA
    J Nucl Biol Med (1991); 1991; 35(4):346-8. PubMed ID: 1726678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. I-131 MIBG detection of metastatic hepatic carcinoid.
    Kipper MS; Krohn L; Grossman PD
    Clin Nucl Med; 1994 Aug; 19(8):751. PubMed ID: 7955766
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.